IIT H’s Gold-Coated Nanoparticles Offer Dual Strike on Skin Cancer
Hyderabad: Scientists from the Indian Institute of Technology (IIT) Hyderabad and the CSIR–Indian Institute of Chemical Technology (CSIR-IICT) have developed an innovative nanoparticle system that holds promise for improving treatment outcomes in melanoma, a serious form of skin cancer. This novel approach not only targets cancer cells but also addresses the secondary fungal infections that often affect immunocompromised cancer patients.
Development of CPAu-NPs
The research team designed gold-coated calcium peroxide nanoparticles, referred to as CPAu-NPs, specifically for use in photothermal therapy (PTT). This treatment method works by converting light into localized heat to destroy cancer cells. Gold nanoparticles were chosen for their exceptional photothermal properties, biocompatibility, and the ease with which their surfaces can be modified.
According to the researchers, the CPAu-NPs provide dual advantages: they generate efficient heat and can intrinsically produce reactive oxygen species (ROS), which are crucial in combating cancer cells.
Research Publication
The findings of this study were published in the journal Communications Chemistry, part of the Nature group. The research was led by Aravind Kumar Rengan from IIT Hyderabad’s Department of Biomedical Engineering, in collaboration with scientists from IICT’s Department of Applied Biology.
Addressing Tumor Hypoxia
A significant challenge in cancer therapy is tumor hypoxia, a condition where the tumor does not receive enough oxygen, which can reduce the effectiveness of treatments. The CPAu-NPs are designed to self-release oxygen and hydrogen peroxide, which helps to overcome this barrier while amplifying oxidative stress within tumor cells.
Combination with Sorafenib
To enhance the efficacy of the treatment, the research team combined the nanoparticles with Sorafenib, a multi-kinase inhibitor known to induce ferroptosis—an iron-dependent form of cell death. Melanoma cells are particularly vulnerable to this type of cell death. The combined strategy aims to disrupt cancer survival pathways, promote lipid peroxidation, and potentially overcome resistance to conventional therapies.
Laboratory Experiments
Laboratory experiments conducted on B16 melanoma cells demonstrated that CPAu-NPs combined with Sorafenib significantly increased cancer cell death under laser irradiation. The treatment also resulted in reduced cell migration and colony formation, indicating a potential impact on metastasis, which is the spread of cancer to other parts of the body.
Antifungal Activity and Immune Response
In addition to their anticancer properties, the CPAu-NPs also exhibited antifungal activity and activated macrophages, which are essential components of the immune response. This suggests that the nanoparticles could improve the immune response in patients who are at risk of infections due to their compromised immune systems.
A Multifunctional Theranostic System
The researchers describe their platform as a “multifunctional theranostic system,” which not only shows promise in controlling tumors but also addresses the risks of infections in vulnerable cancer patients. This dual functionality could significantly enhance the quality of care for patients undergoing cancer treatment.
Future Implications
The development of CPAu-NPs represents a significant advancement in the field of cancer therapy. By combining photothermal therapy with the ability to induce ferroptosis and combat infections, this innovative approach could lead to more effective treatment options for melanoma and potentially other types of cancer.
As the research progresses, further studies will be necessary to evaluate the long-term efficacy and safety of these nanoparticles in clinical settings. The potential to improve patient outcomes in cancer therapy is a promising avenue for future research and development.
Conclusion
The work conducted by the IIT Hyderabad and CSIR-IICT teams highlights the importance of interdisciplinary research in developing innovative solutions to complex medical challenges. The dual-action capability of gold-coated nanoparticles opens new doors for enhanced cancer treatment strategies, offering hope to patients battling melanoma and other forms of cancer.
Note: This article is based on the research findings published in a scientific journal and aims to provide an overview of the advancements in cancer treatment using gold-coated nanoparticles.
